Skip to main content
SpringerLink
Log in
Book cover

Melatonin After Four Decades pp 345–362Cite as

Melatonin Synergizes with Retinoic Acid in the Prevention and Regression of Breast Cancer

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 460))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davis, D.E., Hoel, D., Fox, J., and Lopez, A. International trends in cancer mortality in France, West Germany, Italy, Japan, England, and Wales, and the USA. Lancet 336:474–481, 1990.

    PubMed  CAS  Google Scholar 

  2. Parker, S.L., Tong, T., Bolden, S., and Wingo, P.A. Cancer Statistics. CA Cancer J Clin 65:5–27, 1996.

    Google Scholar 

  3. Jordan, V.C. and Murphy, C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11:578–610, 1991.

    Google Scholar 

  4. Jordan, V.C. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31:41–52, 1994.

    Article  PubMed  CAS  Google Scholar 

  5. Freiss, G., Pretois, C., and Vignon, F. Control of breast cancer growth by steroids and growth factors: Interactions and mechanisms. Breast Cancer Res Treat 27:57–68, 1993.

    Article  PubMed  CAS  Google Scholar 

  6. Knabbe, C., Lippman, M.E., Wadefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., and Dickson, R.B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417–428, 1987.

    Article  PubMed  CAS  Google Scholar 

  7. Blask, D.E. The emerging role of the pineal gland and melatonin in oncogenesis. In: Extremely Low Frequency Eletromagnetic Fields; The Question of Cancer. B.W. Wilson, R.G. Stevens, L.E. Anderson, eds., Battele Press, Columbus, OH, 1990, pp. 319–335.

    Google Scholar 

  8. Blask, D.E. and Hill, S.M. Melatonin and cancer. Basic and clinical perspectives. In: Melatonin-Clinical Persectives. A. Miles, D.R.S. Philbrick, C. Thompson, eds., Oxford Press, New York, 1988, pp.128–173.

    Google Scholar 

  9. Blask, D.E. Melatonin in oncology. In: Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications. H-S Yu, R.J. Reiter, eds., CRC Press, Boca Raton, Florida, 1993, pp. 448–475.

    Google Scholar 

  10. Blask, D.E., Hill, S.M., Orstead, K.M., and Massa, J. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene (DMBA)-induced mammary tumorigenesis. J Neural Trans 67:125–138, 1986.

    Article  CAS  Google Scholar 

  11. Blask, D.E., Pelletier, D.B., Hill, S.M., Lemus-Wilson, A., and Grosso, D. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo. J Cancer Clin Oncol 117:526–532, 1991.

    CAS  Google Scholar 

  12. Kothari, L. and Subramanian A. A possible modulatory influence of melatonin on representative phase I and phase II drug metabolizing enzymes of 9,10-dimethyl-1,2-benzanthracene induced rat mammary tumorigenesis. Anti-Cancer Drugs 3:623–628, 1992.

    PubMed  CAS  Google Scholar 

  13. Hill, S.M., Spriggs, L.L., Simon, M.A., Muraoka, H., and Blask, D.E. The growth inhibitory action of melatonin on human breast cancer cells in linked to the estrogen response system. Cancer Lett 64:249–256, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Soule, M.D., Vazquez, J., Long, A., Albert, S., and Breanan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1413, 1973.

    PubMed  CAS  Google Scholar 

  15. Eckert, R.L. and Katzenellenbogen, B.S. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res 42:139–144, 1982.

    PubMed  CAS  Google Scholar 

  16. Horwitz, K.B., Costlow, M.E., and McGuire, W.L. MCF-7: a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 26:785–795, 1975.

    Article  PubMed  CAS  Google Scholar 

  17. Weinberg, U., E’Elletto, R.D., Weitzman, E.D., Erlich, S., and Hallander, C.S. Circulating melatonin in man: secretion through the light-dark cycle. J Clin Endocrinol and Metab 48:114–118, 1979.

    Article  CAS  Google Scholar 

  18. Molis, T.M., Spriggs, L.L., and Hill, S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrin 8:1681–1690, 1994

    Article  CAS  Google Scholar 

  19. Molis, T.M., Walters, M.R., and Hill, S.M. Melatonin modulation of estrogen receptor mRNA in MCF-7 breast cancer cells. Int J Oncol 3:687–694, 1993.

    CAS  Google Scholar 

  20. Blask, D.E., Cos, S., Hill, S.M., Burns, D.M., Lemus-Wilson, A., Pelletier, D.B., Liaw, L., and Hill, A. Breast cancer: a target for the oncostatic actions of pineal hormones. Adv Pineal Res 4:267–274, 1990.

    CAS  Google Scholar 

  21. Cos, S., Blask, D.E., Lemus-Wilson, A., and Hill, S.M. Effects of melatonin on the cell cycle kinetics and ĺdestrogen-rescue” of MCF-7 human breast cancer cells in culture. J Pineal Res 8:21–27, 1991.

    Google Scholar 

  22. Cos, S., Recio, J., and Sanchez-Barcelo, E.J. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sciences 58:811–816, 1996.

    PubMed  CAS  Google Scholar 

  23. Cos, S., Fernandez, F., and Sanchez-Barcelo, E.J. Melatonin inhibits DNA synthesis in MCF-7 breast cancer cells in vitro. Life Sciences 58:2447–2453, 1996.

    PubMed  CAS  Google Scholar 

  24. Tamarkin, L., Danforth, D., Lichter, A., Demoss, E., Cohen, M., Chabner, B., and Lippman, M. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor-positive breast cancer. Science 216:1003–1005, 1982.

    PubMed  CAS  Google Scholar 

  25. Bartsch, C., Bartsch, H., Jain, A.K., Laumas, K.R., and Wetterberg, L. Urinary melatonin levels in human breast cancer patients. J Neural Trans 52:281–294, 1981.

    CAS  Google Scholar 

  26. Stanberry, L.R., Das Gupta, T.K., and Beattie, C.W. Photoperiodic control of melanoma growth in hamsters: influence of pinealectomy and melatonin. Endocrinology 113:469–475, 1993.

    Google Scholar 

  27. Lissoni, P., Crispino, S., and Barni, S. Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer. Oncology 47:275–277, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Lissoni, P., Barni, S., Meregalli, S., Fossati, V., Cazzaniga, M., Esposti, D., and Tancini, G. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing on tamoxifen alone. Br J Cancer 71:854–856, 1995.

    PubMed  CAS  Google Scholar 

  29. Reppert, S.M., Weaver, D.R., and Ebisawa, T. Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177–1185, 1994.

    PubMed  CAS  Google Scholar 

  30. Birnbaumer, L.G. Proteins in signal transcduction. Ann Rev Pharmac Toxic 30675–705, 1990

    Google Scholar 

  31. Ebisawa, T., Karne, S., Lerner, M.R., and Reppert, S.M. (1994) Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 91:6133–6137, 1994.

    PubMed  CAS  Google Scholar 

  32. Becker-Andre, M., Wiesenberg, I., Schaeren-Wiemers, N., Andre, E., Missbach, M., Saurat, J.-H., and Carlberg, C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Bio Chem 269:28531–2853, 1994.

    CAS  Google Scholar 

  33. Giguere, V., Tini, M., Flock, G., Ong, E., Evans, R.M., and Otulakowski, G. Isoform-specific aminoterminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors. Genes and Develop 8:538–553, 1994.

    CAS  Google Scholar 

  34. Ram, Prahlad. Identification and characterization of the melatonin receptor and its modulation of estrogen receptor phosphorylation and transactivation in MCF-7 human breast tumor cells. Dissertation, pp. 34–42, 1997.

    Google Scholar 

  35. Lotan, R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 60:33–41, 1981.

    Google Scholar 

  36. Roberts, A.B. and Sporn, M.B. Cellular biology and biochemistry of the retinoids. In: The Retinoids, Sporn, M.B., Roberts, A.B., Goodman, D.S., eds.,The Academic Press, Orlando, 1984.

    Google Scholar 

  37. Morris-Kay, G. ed. Retinoids in Normal Development and Teratogenesis. Oxford Science Publications, Oxford, U.K., 1992.

    Google Scholar 

  38. Giguere, V., Ong, E.S., Seigi, P., and Evans, R.M. Identification of a receptor for the morphogen retinoic acid. Nature 330:624–629, 1987.

    Article  PubMed  CAS  Google Scholar 

  39. Pfahl, M. Vertetrate receptors: Molecular biology, dimerization and response elements. Semn in Cell Biol 5:95–103, 1994.

    CAS  Google Scholar 

  40. Yu, V.C., Delsert, C., Andersen, B., Holloway, M.M., Devary, O.V., Nr, A.M., Kim, S.Y., Boutin, J-M., Glass, C.K., and Rosenfeld, M.G. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251–1266, 1991.

    PubMed  CAS  Google Scholar 

  41. Bugge, T.H., Pohl, J., Lonnoy, O., and Stunnenberg, H.G. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 11:1409–1410, 1992.

    PubMed  CAS  Google Scholar 

  42. Zhang, X-K., Hoffman, B., Pran, P., Graupner, G., and Pfahl, M. Retinoid X receptor is an auxillary protein for thyroid hormone and retinoic acid receptors. Nature 355:441–446, 1992.

    PubMed  CAS  Google Scholar 

  43. Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., Gansmuller, A., and Chambon, P. Function of the retinoic acid receptors (RARs) during development (I) Craniofacial and skeletal abnormalities in RAR double mutants. Development 120:2723–2748, 1994.

    PubMed  CAS  Google Scholar 

  44. Mehndelsohn, C., Lohnes, D., Decimo, D., Lufkin, T., LeMeur, M., Chambon, P., and Mark, M. Function of the retinoic acid receptors (RARs) during development (II) Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120:2749–277, 1994.

    Google Scholar 

  45. Graupner, G., Wills, K.N., Tzukerman, M., Zhang, X-K., and Pfahl, M. Dual regulatory role for thyroid hormone receptors allows control of retinoic acid receptor activity. Nature 340:653–656, 1989.

    Article  PubMed  CAS  Google Scholar 

  46. Hermann, T., Hoffmann, B., Piedrafita, J.F., Zhang, X-K., and Pfahl, M. V-erbA requires auxillary proteins for dominant negative activity. Oncogene 8:55–65, 1993.

    PubMed  CAS  Google Scholar 

  47. Apfel, R., Benbrook, D., Lernhard, E., Ortiz-Caseda, M.A., and Pfahl, M. A novel orphan receptor with a unique ligand binding domain and its interaction with the retinoidithyroid hormone receptor superfamily. Mol Cell Biol 14:7025–7035, 1992.

    Google Scholar 

  48. Mangelsdorf, D.J., Umesono, K., Kliewer, S.A., Borgmeyer, U., Ong, E.S., and Evans, R.M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66:555–561, 1991.

    Article  PubMed  CAS  Google Scholar 

  49. Damm, K., Thompson, C.C., and Evans R.M. Protein encode by v-erbA functions as a thyroidhormone receptor antagonist. Nature 339:593–597, 1989.

    Article  PubMed  CAS  Google Scholar 

  50. Zhang, X-K. and Pfahl, M. Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol Metab 4:156–162, 1993.

    CAS  PubMed  Google Scholar 

  51. Lehmann, M.M., Zhang, X-K., Graupner, G., Lee, M-O., Hermann, T., Foffmann, B., and Pfahl, M. Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross-talk by ligand-induced squelching. Mol Cell Biol 13:7698–7707, 1993.

    PubMed  CAS  Google Scholar 

  52. MacDonald, P.N., Dowd, DR., Nakajima, S., Galligan, M.A., Reeder, M.C., Haussler, C.A., Ozato, K., and Hausler, M.R. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cel Biol 13:5907–5917, 1993.

    CAS  Google Scholar 

  53. Schule, R., Umessono, K., Mangelsdorf, D.M., Bolado, J., Pike, J.W., and Evans, R.M. Jon-Fos and receptors for vitamin A and D recognize a common response element in the human osteocalcin gene. Cell 61:497–504, 1990.

    PubMed  CAS  Google Scholar 

  54. Lotan, R. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res 39:1014–1019, 1979

    PubMed  CAS  Google Scholar 

  55. Fontana, J.A., Mezu, A.B., Cooper, B.N., and Miranda D. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res 50: 1997–2002, 1990.

    PubMed  CAS  Google Scholar 

  56. van der Burg, B., van der Leede, B-j.M., Kwkkenbos-Isbrucker, L., Salverda, S., de Laat, S.W., and van der Saag, P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91:149–147, 1993.

    PubMed  Google Scholar 

  57. Fontana, J.A., Burrows-Mezu, A., Clemmons, D.R., and LeRoith, D. Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 28:1115–1122, 1991.

    Google Scholar 

  58. Clarke, C.L., Roman, S.D., Graham, J., Koga, M., and Sutherland, R.L. Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. J Biol Chem 265:12694–12700, 1990.

    PubMed  CAS  Google Scholar 

  59. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J.M., Yahalom, J., Mendelsohn, M., and Miller, W.H. 9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 54:6549–6556, 1994.

    PubMed  CAS  Google Scholar 

  60. Bacus, S.S., Kiguchi, K., Chin, D., King, C.R., and Huberman, E. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface Her-2/neu antigen. Mol Carcinog 3:350–362, 1990.

    PubMed  CAS  Google Scholar 

  61. Moon, R.C., McCormick, D.L., and Mehta, R.G. Inhibition of carcinogenesis by retinoids. Cancer Res 43(Suppl): 2469–2475, 1983.

    CAS  Google Scholar 

  62. Lecrox, A., Koskas, C., and Bhat, PV. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy. Cancer Res 59:5731–5735, 1990.

    Google Scholar 

  63. Gullino, P.M., Pettigres, H.M., and Grahtham, F.M. N-nitrosomethylurea as mammary gand carcinogen in rats. J Natl Cancer Inst 54:401–414, 1975.

    PubMed  CAS  Google Scholar 

  64. Moon, R.C., Hehta, R.G., and Rao, K.V.N. Retinoids and cancer in experimental animals. In: The Retinoids: Biology, Chemistry, and Medicine. Sporn, M.B., Roberts, A.B., and Goodman, D.S., eds., pp. 573–595, Raven Press, New York, 1994.

    Google Scholar 

  65. Gottardis, M., Lamph, M., Shalinsky, W.W., Wellstein, D.R., and Heyman, R.A. The efficacy of 9-cis retinooic acid in experimental models of cancer. Breast Cancer Res Treat 38:85–96, 1996.

    Article  PubMed  CAS  Google Scholar 

  66. Anzano, M.A., Byers, S.W., Smith, J.M., Peer, C.W., Mullen, L.T., Brown, C.C., Roberts, A.B., and Sporn, M.B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent in combination with tamoxifen. Cancer Res 54:4614–4617, 1994.

    PubMed  CAS  Google Scholar 

  67. Costa, A., Formelli, F., Chiesa, F., Decesi, A., De Palo, G., and Veroesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid feretinide. Cancer Res 54:2032–2037s, 1994.

    Google Scholar 

  68. Gottardis, M.M., Bishoff, E.D., Shirley, M.A., Wagoner, M.A., Lamph, W.W., and Heyman, R.A. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): and RXR-selective ligand. Cancer Res 56:5566–5570, 1996.

    PubMed  CAS  Google Scholar 

  69. Bischoff, E.D., Gottardis, M.M., Moon, T.E., Heyman, R.A., and Lamph, W.W. Beyond tamoxifen: The retionid X receptor-selective ligand LGD1069 (Targretin) causes complete regression of mammary carcinoma. Cancer Res 58:479–484, 1998.

    PubMed  CAS  Google Scholar 

  70. Tini, M., Fraser, R.A., and Gigùere, V. Functional interactions between retinoic acid receptors-related orphan nuclear receptor (ROR) and the retinoic acid receptors in the regulation of the γF-crystalline promoter. J Biol Chem 270:20156–20161, 1995.

    PubMed  CAS  Google Scholar 

  71. Eck, K.M., Yuan, L., Duffy, L., Ram, P.T., Ayettey, S., Chen, I., Cohn, C.S., Reed, J.C., and Hill, S.M. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumor cells. Br J Cancer 77:2129–2137, 1998.

    PubMed  CAS  Google Scholar 

  72. Molis, T.M., Spriggs, L.L., Jupiter, Y., and Hill, S.M. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J Pineal Res., 18:93–103, 1995.

    PubMed  CAS  Google Scholar 

  73. Krajewski, S., Blomqvist, C., Franssila, K., Krajewsi, M., Wasenius, V.M., Niskanen, E., Nording, S., and Reed, J.C. Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471–4478, 1995.

    PubMed  CAS  Google Scholar 

  74. Teixeira, C., Reed, J.C., and Pratt, M.A.C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902–3907, 1995.

    PubMed  CAS  Google Scholar 

  75. Hill, S.M. and Blask, D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121–6129, 1988.

    PubMed  CAS  Google Scholar 

  76. Arteaga, C.L., Coffey, R.J., Dugger, T.C., McCutchen, C.M., Moses, H.L., and Lyons, R.M. Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies; evidence for negative autocrine growth regulation by transforming growth factor β. Cell Growth Differ 1:367–374, 1990.

    PubMed  CAS  Google Scholar 

  77. Nicoletti, I., Migliorati, G., Paglancci, M., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271–279, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana, 70112

    Steven M. Hill, Prahlad T. Ram, Louaine L. Spriggs & Kristin M. Eck

  2. Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana, 70112

    Steven M. Hill & Louaine L. Spriggs

  3. Department of Surgery, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana, 70112

    Stephenie Teplitzky

  4. Graduate Program in Molecular and Cellular Biology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana, 70112

    Todd Kiefer

  5. Mary Imogene-Bassett Research Institute, Cooperstown, New York, 13326

    David E. Blask

Authors
  1. Steven M. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephenie Teplitzky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prahlad T. Ram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Todd Kiefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David E. Blask
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Louaine L. Spriggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kristin M. Eck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Hormone and Fertility Research, University of Hamburg, Hamburg, Germany

    James Olcese

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Hill, S.M. et al. (2002). Melatonin Synergizes with Retinoic Acid in the Prevention and Regression of Breast Cancer. In: Olcese, J. (eds) Melatonin After Four Decades. Advances in Experimental Medicine and Biology, vol 460. Springer, Boston, MA. https://doi.org/10.1007/0-306-46814-X_39

Download citation

  • DOI: https://doi.org/10.1007/0-306-46814-X_39

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46134-7

  • Online ISBN: 978-0-306-46814-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation